Novo Nordisk A/S vs Taiwan Semiconductor Manufacturing Company Limited
A head-to-head of Novo Nordisk A/S (NVO) and Taiwan Semiconductor Manufacturing Company Limited (TSMWF) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | NVO | TSMWF |
|---|---|---|
| Market Cap | $182.56B | $447.07B |
| P/E (TTM) | 2.19 | 8.52 |
| Forward P/E | 12.24 | 14.71 |
| P/S | 0.59 | 0.11 |
| P/B | 1.15 | 2.70 |
| EV/EBITDA | 8.12 | 9.34 |
| Dividend Yield | 23.40% | 3.23% |
| Profit Margin | 33.14% | 44.57% |
| Gross Margin | 80.98% | 59.89% |
| Operating Margin | 41.30% | 50.83% |
| Revenue Growth (YoY) | -7.63% | +20.45% |
| FCF Yield | 15.88% | 221.97% |
| Debt / Equity | 67.49 | 16.73 |
| Current Ratio | 0.80 | 2.51 |
Which is better: Novo Nordisk A/S or Taiwan Semiconductor Manufacturing Company Limited?
- ✓Larger by market cap: Taiwan Semiconductor Manufacturing Company Limited
- ✓Cheaper valuation (lower P/E): Novo Nordisk A/S
- ✓Higher dividend yield: Novo Nordisk A/S
- ✓More profitable (net margin): Taiwan Semiconductor Manufacturing Company Limited
- ✓Faster revenue growth: Taiwan Semiconductor Manufacturing Company Limited
- ✓Higher free-cash-flow yield: Taiwan Semiconductor Manufacturing Company Limited
Across 13 available metrics, Taiwan Semiconductor Manufacturing Company Limited leads 7–6.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Novo Nordisk A/S with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.